Kasutatud kirjandus ja lisalugemine

IDevice Icon
  • Azziz R. Hirsutism. Glob Lib Women's Med 2008, DOI 10.3845/GLOWN.10302 http://www.glowm.com/index.html?p=glowm.cml/section_view&articleid=301
  • Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR.Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril. 1999;72:915-925.
  • Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol. 2004;18:685-706.
  • Balen AH, Jacobs HS. A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil Steril 1994;62:921-925.
  • Balen AH, Laven JSE, Tan S-L, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definition. Human Reprod Update 2003;9:505-514.
  • Balen AH, Platteau P, Andersen AN, Devroey P, Sorensen P, Helmgaard L, et al. The influence of body weight on response to vulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 2006;113:1195–202.
  • Barnes RB, Rosenfield RL. Masculinization of the human pituitary-ovarian axis by perinatal androgen exposure: Polycystic ovary syndrome (PCOS) in congenital adrenal virilizing disease (CAVD). Endocrinology 1991; 128 (suppl):335.
  • Bidet M, Bellanné-Chantelot C, Galand-Portier MB, Golmard JL, Tardy V, Morel Y, Clauin S, Coussieu C, Boudou P, Mowzowicz I, Bachelot A, Touraine P, Kuttenn F. ertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010;95(3):1182-1190.
  • Campo S. Ovulatory cycles, pregnancy outcome and complications after surgical treatment of polycystic ovary syndrome. Obstet Gynecol Surv 1998; 53:297-308.
  • Cheng J, Lv J, Li CY, Xue Y, Huang Z, Zheng W.Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome. J Int Med Res. 2010;38(4):1250-1258.
  • Ciotta L, Cianci A, Calogero AE et al. Clinical and endocrine effects of finasteride, a 5alpha-reductase inhibitor, in women with idiopathic hirsutism. Fertil Steril 1995;64:299-306.
  • Dacou-Voutetakis C, Dracopoulou M. Non-classical congenital adrenal hyperplasia. Pediatr Endocrinol Rev. 2006;3 Suppl 1:195-197.
  • DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-23.
  • Dhom G. The prepubertal and pubertal growth of adrenal (adrenarche). Beitr Pathol. 1973; 150:357
  • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774-800.
  • Dunaif A, Abraham T. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 2001; 52:401-419.
  • Fanta M, Hill M, Belácek J, Vrbíková J, Cibula D.Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: a prospective study. Gynecol Endocrinol. 2009;25(6):398-402.
  • Futterweit W. Polycystic Ovary Syndrome: Clinical Perpectives and Management. Obstetr Gynecol Surv 1999; 54: 403-413.
  • Gjonnaess H. Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results. Acta Obstet Gynecol Scand 1994;73:407–12.
  • Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815-830.
  • Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1999;84:1617–1622.
  • Johnson NP, Stewart AW, Falkiner J, Farquhar CM, Milsom S, Singh VP, Okonkwo QL, Buckingham KL; REACT-NZ (REproduction And Collaborative Trials in New Zealand), a multi-centre fertility trials group. PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene. Hum Reprod. 2010;25(7):1675-1678.
  • Kazerooni T, Dehghan-Kooshkghazi M.Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Gynecol Endocrinol. 2003;17(1):51-56.
  • Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36(1):105-111.
  • Legro RS, Azziz R. Androgen excess disorders. In: Gibbs RS, Karlan bY, Haney AF, Nygaard I (eds.) Danforth's Obstetrics and gynecology 10th ed. Philadelphia: Wolters Kluwer/Lippingott Williams & Wilkins 2008; 698-704.
  • Marshall JC, Dalkin AC, Haisenleder DJ, Paul SJ, Ortolano GA, Kelch RP.Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles. Recent Prog Horm Res. 1991;47:155-187; discussion 188-189.
  • Massafra C, De Felice C, Agnusdei DP, Gioia D, Bagnoli F. Androgens and osteocalcin during the menstrual cycle. JCEM 1999; 82 (3): 971-974.
  • Mathur R, Levin O, Azziz R.Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag. 2008; 4(2):487-492.
  • McGee EA and Hsueh AJW. Initial and Cyclic Recruitment of Ovarian Follicles Endocr Rev. 2000; 21 (2): 200-214.
  • Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 2006;332:1485.
  • Moller DE, Flier JS: Insulin resistance: Mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938- 948.
  • Moran C, Knochenhauer E, Boots L, Azziz R. Adrenal andregen excess in hyperandrogenism:relation to age and body mass. Fertil Steril 1999; 71: 671-674
  • Muniyappa R, Lee S, Chen H, Quon MJ.Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15-26.
  • Palomba S, Pasquali R, Orio F Jr, Nestler JE. Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis.Clin Endocrinol (Oxf). 2009;70(2):311-321.
  • Parkel L, Odell WD. Control of adrenal androgen secretion. Endocr Rev. 1980; 1:392
  • Rosenfield RL. The ovary and female sexual maturation. In: Kaplan SA (ed). Clinical Pediatric Endocrinology. 2nd ed. Philadelphia:WB Saunders, 1989,p 259
  • Rosenfield RL, Cara JF. Androgens and the Adolescent. In: Sanfilippo JS, Muram D, Lee P. (eds) Pediatric and Adolescent Gynecology.1st ed. WB Saunders Co, 1994.
  • Safar FH, Mojiminiyi OA, Al-Rumaih HM, Diejomaoh MF. Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age. Clin Chem. 2011;57(2):279-85.
  • Steimer Th. Steroid hormone metabolism http://www.gfmer.ch/Books/Reproductive_health/Steroid_hormone_metabolism.html
  • Strickler JH, Garrett AB: Androgen excess and hair loss in women. In Azziz R, Nestler JE, Dewailly D (eds): Androgen Excess Disorders in Women, Philadelphia: Lippincott-Raven, 1977; p 141.
  • Tolino A, Gambardella V, Caccavale C, D'Ettore A, Giannotti F, D'Antò V, De Falco CL. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2005;119(1):87-93.
  • Uno H. Biology of hair growth. Semin Reprod Endocrinol 1986; 4: 131.
  • Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004;19:1734–1740.
  • Vrbíková J, Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome. Hum Reprod Update. 2005;11(3):277-291.

« Previous

Kristiina Rull (2011), Tartu Ülikool